학술논문
Irbesartan ameliorates diabetic nephropathy by activating the Nrf2/Keap1 pathway and suppressing NLRP3 inflammasomes in vivo and in vitro
Document Type
Article
Author
Source
In International Immunopharmacology 20 April 2024 131
Subject
Language
ISSN
1567-5769